Suppr超能文献

重组 Intimin、EspB 和志贺毒素 2B 疫苗对大肠杆菌 O157:H7 攻毒犊牛的效力。

Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.

机构信息

Instituto de Patobiología, Centro de Investigación en Ciencias Veterinarias y Agronómicas, Instituto Nacional de Tecnología Agropecuaria (INTA), Hurlingham, Argentina.

Laboratorio de Fisiopatogenia, Departamento de Fisiología, Instituto de Fisiología y Biofísica Bernardo Houssay (IFIBIO Houssay-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

出版信息

Vaccine. 2018 Jun 22;36(27):3949-3959. doi: 10.1016/j.vaccine.2018.05.059. Epub 2018 May 26.

Abstract

Escherichia coli O157:H7 is a zoonotic pathogen of global importance and the serotype of Shiga toxin-producing E.coli (STEC) most frequently associated with Hemolytic Uremic Syndrome (HUS) in humans. The main STEC reservoir is cattle. Vaccination of calves with the carboxy-terminal fraction of Intimin γ (IntC280) and EspB can reduce E.coli O157:H7 fecal shedding after experimental challenge. Shiga toxin (Stx) exerts local immunosuppressive effects in the bovine intestine and Stx2B fused to Brucella lumazine synthase (BLS-Stx2B) induces Stx2-neutralizing antibodies. To determine if an immune response against Stx could improve a vaccine's effect on fecal shedding, groups of calves were immunized with EspB + IntC280, with EspB + IntC280 + BLS-Stx2B, or kept as controls. At 24 days post vaccination calves were challenged with E.coli O157:H7. Shedding of E.coli O157:H7 was assessed in recto-anal mucosal swabs by direct plating and enrichment followed by immunomagnetic separation and multiplex PCR. Calves were euthanized 15 days after the challenge and intestinal segments were obtained to assess mucosal antibodies. Vaccination induced a significant increase of IntC280 and EspB specific antibodies in serum and intestinal mucosa in both vaccinated groups. Antibodies against Stx2B were detected in serum and intestinal mucosa of animals vaccinated with 3 antigens. Sera and intestinal homogenates were able to neutralize Stx2 verocytotoxicity compared to the control and the 2-antigens vaccinated group. Both vaccines reduced E.coli O157:H7 shedding compared to the control group. The addition of Stx2B to the vaccine formulation did not result in a superior level of protection compared to the one conferred by IntC280 and EspB alone. It remains to be determined if the inclusion of Stx2B in the vaccine alters E.coli O157:H7 shedding patterns in the long term and after recurrent low dose exposure as occurring in cattle herds.

摘要

产志贺毒素大肠杆菌 O157:H7 是一种具有全球重要意义的人畜共患病病原体,也是与人类溶血性尿毒症综合征(HUS)最相关的产志贺毒素大肠杆菌(STEC)血清型。该病原体的主要储存宿主是牛。用 Intimin γ(IntC280)羧基末端片段和 EspB 对小牛进行疫苗接种,可以减少大肠杆菌 O157:H7 实验性攻毒后的粪便脱落。志贺毒素(Stx)在牛的肠道中发挥局部免疫抑制作用,而融合了布鲁氏菌尿嘧啶合酶(BLS-Stx2B)的 Stx2B 可以诱导 Stx2 中和抗体。为了确定针对 Stx 的免疫反应是否可以改善疫苗对粪便脱落的效果,将小牛分为 EspB+IntC280 免疫组、EspB+IntC280+BLS-Stx2B 免疫组和对照组。在疫苗接种后 24 天,用大肠杆菌 O157:H7 对小牛进行攻毒。通过直接平板培养和富集后进行免疫磁珠分离和多重 PCR,从直肠黏膜拭子中评估大肠杆菌 O157:H7 的脱落情况。攻毒后 15 天,对小牛进行安乐死,并获得肠道段以评估黏膜抗体。疫苗接种在两组疫苗接种的小牛的血清和肠道黏膜中诱导了 IntC280 和 EspB 特异性抗体的显著增加。在接种了 3 种抗原的动物的血清和肠道黏膜中检测到针对 Stx2B 的抗体。与对照组和接种了 2 种抗原的组相比,血清和肠道匀浆能够中和 Stx2 的细胞毒性。与对照组相比,两种疫苗均减少了大肠杆菌 O157:H7 的脱落。与单独使用 IntC280 和 EspB 相比,在疫苗配方中添加 Stx2B 并没有导致更高水平的保护。尚待确定 Stx2B 是否会改变疫苗接种后长期和牛群中反复低剂量暴露后大肠杆菌 O157:H7 的脱落模式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验